These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23340239)

  • 21. Management of HCV and HIV infections among people who inject drugs.
    Grebely J; Tyndall MW
    Curr Opin HIV AIDS; 2011 Nov; 6(6):501-7. PubMed ID: 22001894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies for managing hepatitis C virus infection in HIV-infected patients.
    Clanon KA
    Top HIV Med; 2003; 11(2):50-4. PubMed ID: 12717042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunodeficiency virus and hepatitis C virus co-infection.
    Vlahakis SR
    J Med Liban; 2006; 54(2):106-10. PubMed ID: 17087002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Social determinants of health associated with hepatitis C co-infection among people living with HIV: results from the Positive Spaces, Healthy Places study.
    Rourke SB; Sobota M; Tucker R; Bekele T; Gibson K; Greene S; Price C; Koornstra JJ; Monette L; Byers S; Watson J; Hwang SW; Guenter D; Dunn J; Ahluwalia A; Wilson MG; Bacon J;
    Open Med; 2011; 5(3):e120-31. PubMed ID: 22046224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of human immunodeficiency virus on viral hepatitis.
    Mallet V; Vallet-Pichard A; Pol S
    Liver Int; 2011 Jan; 31 Suppl 1():135-9. PubMed ID: 21205151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life.
    Cacoub P; Rosenthal E; Halfon P; Sene D; Perronne C; Pol S
    J Viral Hepat; 2006 Oct; 13(10):678-82. PubMed ID: 16970599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of clinical outcomes between HIV-infected patients with and without HCV co-infection in a resource-limited setting.
    Than NN; Sungkanuparph S; Maek-A-Nantawat W; Kaewkungwal J; Pitisuttithum P
    Southeast Asian J Trop Med Public Health; 2012 May; 43(3):646-51. PubMed ID: 23077844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Needs assessment and coping strategies of persons infected with HIV in Egypt.
    Kabbash IA; El-Gueneidy M; Sharaf AY; Hassan NM; Al-Nawawy N
    East Mediterr Health J; 2008; 14(6):1308-20. PubMed ID: 19161106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hepatitis C virus in human immunodeficiency virus infected patients in "real life": modifications in two large surveys between 2004 and 2006.
    Cacoub P; Halfon P; Rosenthal E; Pialoux G; Benhamou Y; Perronne C; Pol S;
    J Hepatol; 2008 Jan; 48(1):35-42. PubMed ID: 17945375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients' experiences related to anti-viral treatment for hepatitis C.
    Fraenkel L; McGraw S; Wongcharatrawee S; Garcia-Tsao G
    Patient Educ Couns; 2006 Jul; 62(1):148-55. PubMed ID: 16098705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of control selection on sustained viral response rates in genotype 2/3 HCV mono-infected versus HIV/HCV co-infected patients.
    Nilsson J; Weiland O
    Scand J Infect Dis; 2010 Jul; 42(6-7):533-9. PubMed ID: 20214543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The context and experience of becoming HIV infected for Zimbabwean women: unheard voices revealed.
    Gona CM; DeMarco R
    J Assoc Nurses AIDS Care; 2015; 26(1):57-68. PubMed ID: 24823287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Life With HIV: Insights from HIV-infected Women in Cameroon, Central Africa.
    Alomepe J; Buseh AG; Awasom C; Snethen JA
    J Assoc Nurses AIDS Care; 2016; 27(5):654-66. PubMed ID: 27260684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient perspectives on hepatitis C and its treatment.
    North CS; Devereaux R; Pollio DE; Hong BA; Jain MK
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):74-81. PubMed ID: 23788155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do we need to address stigma and mistrust to facilitate hepatitis C elimination among people living with HIV?
    Cachay E
    AIDS; 2020 Feb; 34(2):325-331. PubMed ID: 31876595
    [No Abstract]   [Full Text] [Related]  

  • 37. Living with Hepatitis C Virus: A Systematic Review and Narrative Synthesis of Qualitative Literature.
    Dowsett LE; Coward S; Lorenzetti DL; MacKean G; Clement F
    Can J Gastroenterol Hepatol; 2017; 2017():3268650. PubMed ID: 28529936
    [No Abstract]   [Full Text] [Related]  

  • 38. The Experience of Growing Old While Living With HIV in Spain: A Phenomenological Study.
    Leyva-Moral JM; Martínez-Batlle F; Vázquez-Naveira M; Hernández-Fernández J; Villar-Salgueiro M
    J Assoc Nurses AIDS Care; 2019; 30(1):111-118. PubMed ID: 30586088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The experience of hepatitis C treatment for people with a history of mental health problems: An interpretative phenomenological analysis.
    Ware K; Davies J; Rowse G; Whittaker S
    J Health Psychol; 2015 Jul; 20(7):990-1001. PubMed ID: 24155196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C in a new therapeutic era: Recontextualising the lived experience.
    Whiteley D; Whittaker A; Elliott L; Cunningham-Burley S
    J Clin Nurs; 2018 Jul; 27(13-14):2729-2739. PubMed ID: 28960567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.